Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
20.57 USD | -5.25% | -4.15% | -26.67% |
05-09 | Wedbush Adjusts Pharvaris' Price Target to $31 From $35, Maintains Outperform Rating | MT |
05-08 | Pharvaris N.V. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
PHARVARIS N.V. | Other Biotechnology & Medical Research | -5.25% | -4.15% | -26.67% | +142.00% | - | 1.17B |
Technical Rankings Surperformance
- Stock Market
- Equities
- PHVS Stock
- Charts Pharvaris N.V.
- Comparison Chart